Cargando…

Integrated Analysis Revealed Prognostic Factors for Prostate Cancer Patients

BACKGROUND: Prostate cancer (PCa) is one of the major causes of cancer-induced death among males. Here, we applied integrated bioinformatics analysis to identify key prognostic factors for PCa patients. MATERIAL/METHODS: The gene expression data were obtained from the UCSC Xena website. We calculate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Che, Hong, Liu, Yi, Zhang, Meng, Meng, Jialin, Feng, Xingliang, Zhou, Jun, Liang, Chaozhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2019
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944160/ https://www.ncbi.nlm.nih.gov/pubmed/31876269 http://dx.doi.org/10.12659/MSM.918045

Ejemplares similares

The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer
por: Meng, Jialin, et al.
Publicado: (2019)

Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin Ratio, Platelets, Sex, and Fibrinogen in Predicting Recurrence-Free Survival Time of Renal Cancer
por: Bian, Zichen, et al.
Publicado: (2020)

Fifteen-MiRNA-Based Signature Is a Reliable Prognosis-Predicting Tool for Prostate Cancer Patients
por: Bian, Zichen, et al.
Publicado: (2021)

Characterization of the prognostic values and response to immunotherapy/chemotherapy of Krüppel‐like factors in prostate cancer
por: Meng, Jialin, et al.
Publicado: (2020)

A New Nomogram Allowing Physicians to Predict Patients at High Risk of Fever Occurring After Prostate Biopsy
por: Xia, Haoran, et al.
Publicado: (2020)

Integrated multi‐omics data reveals the molecular subtypes and guides the androgen receptor signalling inhibitor treatment of prostate cancer
por: Meng, Jialin, et al.
Publicado: (2021)

Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Coexpression Analysis and Clinical Validation
por: Feng, Xingliang, et al.
Publicado: (2020)

Risk subtyping and prognostic assessment of prostate cancer based on consensus genes
por: Meng, Jialin, et al.
Publicado: (2022)

hOGG1 rs1052133 Polymorphism and Prostate Cancer Risk: A Chinese Case-Control Study and Meta-Analysis
por: Xu, Hanjiang, et al.
Publicado: (2022)

The association of HIF-1α expression with clinicopathological significance in prostate cancer: a meta-analysis
por: Huang, Meng, et al.
Publicado: (2018)

EPM2A acts as a protective factor in prostate cancer, evidence from a real-world patient cohort
por: Ge, Qintao, et al.
Publicado: (2022)

Immune response drives outcomes in prostate cancer: implications for immunotherapy
por: Meng, Jialin, et al.
Publicado: (2020)

A novel nomogram and risk classification system predicting the overall survival of patients with papillary renal cell carcinoma after nephrectomy: A population-based study
por: Hu, Yongtao, et al.
Publicado: (2022)

Establishment of a five‐enzalutamide‐resistance‐related‐gene‐based classifier for recurrence‐free survival predicting of prostate cancer
por: Chen, Jing, et al.
Publicado: (2022)

Nomogram for predicting the overall survival of patients with early‐onset prostate cancer: A population‐based retrospective study
por: Hu, Yongtao, et al.
Publicado: (2022)

In silico validation of a new classifier, PCSCG(ier), for predicting recurrence‐free survival in prostate cancer patients: Evidence from multiple datasets
por: Zhang, Meng, et al.
Publicado: (2023)

Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy
por: Ge, Qintao, et al.
Publicado: (2023)

Do polymorphisms in protein kinase catalytic subunit alpha-1 gene associated with cancer susceptibility? a meta-analysis and systematic review
por: Meng, Jialin, et al.
Publicado: (2018)

Establishment of an age‐ and tumor microenvironment‐related gene signature for survival prediction in prostate cancer
por: Chen, Lei, et al.
Publicado: (2022)

Polymorphisms in ERCC2 and ERCC5 and Risk of Prostate Cancer: A Meta-Analysis and Systematic Review
por: Liu, Yi, et al.
Publicado: (2018)

Overexpression of DDX49 in prostate cancer is associated with poor prognosis
por: Tao, Junyue, et al.
Publicado: (2023)

Development and external validation of a nomogram for predicting renal function based on preoperative data from in-hospital patients with simple renal cysts
por: Chen, Yiding, et al.
Publicado: (2022)

Targeting the Lnc-OPHN1-5/androgen receptor/hnRNPA1 complex increases Enzalutamide sensitivity to better suppress prostate cancer progression
por: Zhang, Meng, et al.
Publicado: (2021)

Does miR-618 rs2682818 variant affect cancer susceptibility? Evidence from 10 case–control studies
por: Feng, Xingliang, et al.
Publicado: (2019)

Single‐cell multi‐omics analysis presents the landscape of peripheral blood T‐cell subsets in human chronic prostatitis/chronic pelvic pain syndrome
por: Zhang, Meng, et al.
Publicado: (2020)

Identification of a Costimulatory Molecule-Related Signature for Predicting Prognostic Risk in Prostate Cancer
por: Ge, Shengdong, et al.
Publicado: (2021)

Integrated analysis reveals prognostic value and progression-related role of AMIGO2 in prostate cancer
por: Han, Zhaodong, et al.
Publicado: (2022)

Clinical Features of 167 Inpatients with Autosomal Dominant Polycystic Kidney Disease at a Single Center in China
por: Meng, Jialin, et al.
Publicado: (2018)

The established chemokine-related prognostic gene signature in prostate cancer: Implications for anti-androgen and immunotherapies
por: Chen, Lei, et al.
Publicado: (2022)

Association between MMP2-1306 C/T polymorphism and prostate cancer susceptibility: a meta-analysis based on 3906 subjects
por: Zhang, Kaiping, et al.
Publicado: (2017)

Metabolomics Analysis Reveals the Differential Metabolites and Establishes the Therapeutic Effect Prediction Nomogram Among CP/CPPS Patients Who Respond or Do Not Respond to LiST
por: Meng, Jialin, et al.
Publicado: (2022)

TP73 G4C14-A4T14 polymorphism and cancer susceptibility: evidence from 36 case–control studies
por: Meng, Jialin, et al.
Publicado: (2018)

Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer‐specific survival of patients with kidney cancer
por: Zhou, Yuan, et al.
Publicado: (2020)

Identifying Long Non-coding RNA of Prostate Cancer Associated With Radioresponse by Comprehensive Bioinformatics Analysis
por: Xu, Meng, et al.
Publicado: (2020)

The Urinary Sarcosine/Creatinine Ratio is a Potential Diagnostic and Prognostic Marker in Prostate Cancer
por: Wang, Meng, et al.
Publicado: (2018)

Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer
por: Liu, Xinkui, et al.
Publicado: (2020)

Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia
por: Yu, Haining, et al.
Publicado: (2015)

Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy
por: Meng, Jialin, et al.
Publicado: (2021)

Landscape of the intratumroal microenvironment in bladder cancer: Implications for prognosis and immunotherapy
por: Bian, Zichen, et al.
Publicado: (2022)

Higher Intake of Fat, Vitamin E-(β+γ), Magnesium, Sodium, and Copper Increases the Susceptibility to Prostatitis-like Symptoms: Evidence from a Chinese Adult Cohort
por: Zhang, Meng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lak28k2mfg1apage9dicrmkr1r